Guest guest Posted January 18, 2007 Report Share Posted January 18, 2007 Scientific American, Feb 2007 (brand new issues), pp.66-69, article " Spice Healer " , about curcuma longa. Research, rooted in Indian usages, finds " multiple pathway " beneficial effects, e.g. in various cancers, possibly Alzheimers, RA, IBS, etc. One researcher recommends simply 8 gr daily as a supplement -- that's in line with CM dosaging. Discussion of the research and biomechanical mechanisms, together with discussion of skepicism, and counter research. And mention of the patent issues and lack (or unfruitful) interest on the part of big pharma. This sort of " science " strikes me as imminently compatible, useable from a CM perspective. -- Version: 7.5.432 / Virus Database: 268.16.14/636 - Release 1/18/2007 4:00 AM Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 18, 2007 Report Share Posted January 18, 2007 Hi Chris & dear list members, >>And mention of the patent issues and lack (or unfruitful) interest on the part of big pharma.<< in a way, the big companies are doing a severe mistake; it might be better to invest some R & D efforts in ethnic medicines/remedies and during " the walking the way " the company eventually will find ways to protect the investors money (=patent). It happened so many times in the past, but it takes great CEOs to see the light at the end of the tunnel... Dr. Sagiv Ben-Yakir BSC DVM(in honor) MRCVS CVA(IVAS) benyakir - Chinese Medicine Thursday, January 18, 2007 9:56 AM jiang huang -fascinating science article Scientific American, Feb 2007 (brand new issues), pp.66-69, article " Spice Healer " , about curcuma longa. Research, rooted in Indian usages, finds " multiple pathway " beneficial effects, e.g. in various cancers, possibly Alzheimers, RA, IBS, etc. One researcher recommends simply 8 gr daily as a supplement -- that's in line with CM dosaging. Discussion of the research and biomechanical mechanisms, together with discussion of skepicism, and counter research. And mention of the patent issues and lack (or unfruitful) interest on the part of big pharma. This sort of " science " strikes me as imminently compatible, useable from a CM perspective. -- Version: 7.5.432 / Virus Database: 268.16.14/636 - Release 1/18/2007 4:00 AM Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.